Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Spotify is attempting to give users more control over the music the streaming service recommends with a new playlist feature called "Prompted Playlist." The beta feature is rolling out in New Zealand ...

With its playlist chatbot, Spotify says you could ‘curate your next Discover Weekly, exactly the way you want it.’ With its playlist chatbot, Spotify says you could ‘curate your next Discover Weekly ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Spotify announced on Wednesday that, for the first time, it’s giving users more control over the streaming service’s algorithm. That’s at least how the company is framing the launch of its new ...

Track down that song you didn't catch the name of. Or discover more music like what you just heard. Here's what Studio One is playing today.